Physician profile
Heather J Cottage
NPI 1255811782
$712.26
in general payments reported to CMS, 2019-2025
9 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.60 · 2023: $201 · 2024: $231 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Education: $74.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.36 |
| Education | $74.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $226.05 | 2022-2024 | Wegovy, Saxenda |
| Medical Device Business Services, INC. | $204.77 | 2025 | Evarrest |
| Lilly USA, LLC | $142.22 | 2023-2024 | Zepbound, Jardiance |
| Braintree Laboratories, INC. | $36.59 | 2023 | Sutab |
| Organogenesis INC. | $29.62 | 2024 | |
| Merck Sharp & Dohme LLC | $27.73 | 2023 | Keytruda, Lynparza |
| Solventum Corporation | $15.95 | 2024 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $14.73 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $14.60 | 2024 | Echelon Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Cottage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.